Specialty / Expertise

Genitorurinary cancers

Research Interests

Intermittent androgen suppression and the effects of androgen deprivation on the male mind and body

Current Research Projects

Research Staff

Training

Dr. Higano received her MD from University of Massachusetts Worcester, Massachusetts. She completed her Internal Medicine Residency at the Mayo Graduate School of Medicine, Rochester, Minnesota. She was a Post-Doctoral Fellow in Oncology at the University of Washington and Fred Hutchinson Cancer Research Center, Seattle, WA.

Selected Publications:

Scher HI, Halabi S, Tannock I, Morris M, Sternberg C, Carducci M, Eisenberger MA, Higano CS, Bubley GJ, Dreicer R, Petyrlak D, Kantoff P, Heller G, Basch E, Kelly WK, Figg WD, Small EJ, Beer TM, Wilding G, Martin A, Hussain M. Design and endpoints of Phase 2 trials for patients with progressive prostate cancer and castrate levels of testosterone. Recommendation of the Prostate Cancer Trials Working Group (PCWG2). J Clin Oncol 2008 26(7):1148-1159.

Higano CS, Tangen CM, Sakr WA, Faulkner J, Rivkin SE, Gandara DR, Hussain M, Baker LH, Russell KJ, Raghavan D, Crawford ED; Southwest Oncology Group Trial 8733. Treatment options for muscle invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, adriamycin, and cisplatin: report of Southwest Oncology Group Trial 8733. Cancer 2008 112(10):2181-2187.

Wright JL, Higano CS, Lin DW. Intermittent androgen deprivation: Clinical experience and practical applications. Urol Clin North Am, 2006, 33:167-179.

Higano CS. Current status of treatment for patients with metastatic prostate cancer. Can J Urol 2005, 12 Suppl 2:38-41.

Higano CS. Counseling patients on choice of therapy: Medical Oncologist perspective. In Management of Prostate Cancer, E Klein (ed). Humana Press, 491-500, 2004.

Diamond TH, Higano CS, Smith MR, Guise TA, Singer FR. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 2004, 100:592-899.

Higano CS. Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician. Urol Clin North Am, 2004, 31:331-352.

Higano CS. Androgen-deprivation therapy for prostate cancer. Clin Prostate Ca, 2003, 2:22-23.

Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003, 61(suppl 2A):32-38.

Higano CS. Management of bone loss in men with prostate cancer. J Urol 2003, 170:S59-S64.

Higano CS. Bone loss and the evolving role of bisphosphonate therapy in prostate cancer. Urol Oncol 2003, 21:392-398.